Focus Stocks
WuXi PharmaTech Schedules Second-Quarter 2012 Earnings Release
Published on Wednesday, 11 July 2012 22:16 Written by TradersHuddle Staff
SHANGHAI, July 11, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 2012 after the New York Stock Exchange closes on Monday, August 13, 2012 (which will be Tuesday morning, August 14, 2012 Shanghai time). The earnings release will be available on the investor relations section of the Company's website at http://www.wuxiapptec.com/.
Following the earnings announcement, WuXi PharmaTech senior management will host a conference call at 8:00 am (U.S. Eastern) / 5:00 am (U.S. Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) on Tuesday, August 14, 2012, to discuss the second-quarter 2012 financial results and recent business activities. The conference call may be accessed by calling:
|
United States: |
1-866-519-4004 |
|
China (Landline): |
800-819-0121 |
|
China (Mobile): |
400-620-8038 |
|
Hong Kong: |
800-930-346 |
|
United Kingdom: |
0-808-234-6646 |
|
International: |
+65-6723-9381 |
|
Conference ID: |
10406942 |
A telephone replay will be available two hours after the call's completion at:
|
United States: |
1-866-214-5335 |
|
China North: |
10-800-714-0386 |
|
China South: |
10-800-140-0386 |
|
Hong Kong: |
800-901-596 |
|
United Kingdom: |
0-800-731-7846 |
|
International: |
+61-2-8235-5000 |
|
Conference ID: |
10406942 |
A live webcast of the conference call and replay will be available in the investor relations section of WuXi PharmaTech's website at http://www.wuxiapptec.com/.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.
For more information, please contact:
Ronald Aldridge
Director of Investor Relations
WuXi PharmaTech (Cayman) Inc.
Tel: +1-201-585-2048
Email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.
Web: http://www.wuxiapptec.com
SOURCE WuXi PharmaTech (Cayman) Inc.
Related Articles
- /C O R R E C T I O N -- WuXi PharmaTech (Cayman) Inc./
- WuXi PharmaTech Announces First-Quarter 2013 Results
- WuXi PharmaTech Files 2012 Annual Report on Form 20-F
- WuXi PharmaTech Schedules First-Quarter 2013 Earnings Release
- WuXi PharmaTech Receives Letter from AAALAC Commending Animal Care at Suzhou Toxicology Facility as "Exemplary"
- WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
- WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
Related Partner Headlines
- UPDATE: Bank of America Reduces PO to $19 on WuXi PharmaTech on Mixed Outlook - Benzinga
- UPDATE: Credit Suisse Upgrades WuXi PharmaTech to Outperform on Growth Drivers - Benzinga
- From Earlier: WuXi PharmaTech Receives GLP Statement for Suzhou Toxicology Facility - Benzinga
- UPDATE: Deutsche Bank Raises WuXi PharmaTech's PT - Benzinga
- Oppenheimer Reiterates Outperform Rating, $22 PT for WuXi PharmaTech - Benzinga
- From Earlier: WuXi PharmaTech Announces Purchase of Ordinary Shares from General Atlantic - Benzinga
- WuXi PharmaTech (Cayman) Inc. Stock Upgraded (WX) - TheStreet.com
- WuXi PharmaTech (Cayman Stock Hits New 52-Week Low (WX) - TheStreet.com
- WuXi PharmaTech (Cayman Stock Hits New 52-Week Low (WX) - TheStreet.com
- WuXi PharmaTech (Cayman) Inc. Stock Downgraded (WX) - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
-
Chesapeake Energy Is Close to Resistance -
Windstream Is Near its 50 Day Moving Average -
Applied Materials Is Close to Resistance -
E*TRADE is Near a Key Support Area -
First Solar is Near a Key Support Area -
Trading Idea: Is Monster Worldwide close to Support? -
Trading Idea: - Is Walgreen close to Resistance?
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,303.10 Trade time:4:36PM EDT Value change:▲8.60 (0.06%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,649.60 Trade time:4:35PM EDT Value change:▼0.91 (-0.06%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,459.14 Trade time:5:15PM EDT Value change:▼0.28 (-0.01%)In The Wires
-
Restaurant Social Media Management Service Launches In Tampa, Florida -
Adam Paul Green, & "Xocai Taiwan" Announces New MXI Corp Xophoria Anti-Aging Spot Treatment, with the Antioxidant Power of Dark Cocoa for Distributors in Tainan City -
Credit Card Consolidation Loan Believes Debt Will Go Even Lower As Household Wealth Continues To Rise -
What Can Hospital Leaders Learn from a Flock of Geese? -
National EMR Expert, Nitin Chhoda, Reveals How to Avoid the Top 10 Causes of Insurance Denial Claims -
New LoanLove.com Guide Helps Homeowners Choose The Best Loan Options -
How Moving.com has Made Moving Easy with their Newly Revised Website -
New Product from Sublime Beauty®: "Pure Pleasure Foot Balm" Can Help With Relaxation This Holiday Weekend








